SEC Filings | Tango Therapeutics, Inc

Filing date	Description	Form	View
Sep 29, 2021	EFFECT	EFFECT	9999999995-21-003701.pdf 9999999995-21-003701.rtf 9999999995-21-003701.xls View HTML
Mar 31, 2022	EFFECT	EFFECT	9999999995-22-000785.pdf 9999999995-22-000785.rtf 9999999995-22-000785.xls View HTML
Sep 12, 2022	EFFECT	EFFECT	9999999995-22-002669.pdf 9999999995-22-002669.rtf 9999999995-22-002669.xls View HTML
Sep 28, 2022	EFFECT	EFFECT	9999999995-22-002840.pdf 9999999995-22-002840.rtf 9999999995-22-002840.xls View HTML
Sep 11, 2023	EFFECT	EFFECT	9999999995-23-002627.pdf 9999999995-23-002627.rtf 9999999995-23-002627.xls View HTML
Apr 26, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0000950170-22-006138.pdf 0000950170-22-006138.rtf View HTML
Apr 24, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-23-112957.pdf 0001193125-23-112957.rtf View HTML
Apr 26, 2022	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0000950170-22-006137.pdf 0000950170-22-006137.rtf 0000950170-22-006137.xls View HTML
Apr 24, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0000950170-23-014108.pdf 0000950170-23-014108.rtf 0000950170-23-014108.xls View HTML
Apr 29, 2024	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0000950170-24-049881.pdf 0000950170-24-049881.rtf 0000950170-24-049881.xls View HTML

Data provided by Kaleidoscope.